Testing effectiveness (Phase 2)Study completedNCT00695409
What this trial is testing
Yttrium-90 Ibritumomab Tiuxetan Plus High-Dose BEAM Followed By ASCT For Relapsed B-Cell Non-Hodgkin Lymphoma
Who this might be right for
Lymphoma
City of Hope Medical Center 122